ane/EtOAc '1:1, 0.4 L), EtOAc '0.4 L), EtOH '0.4 L) at 4.8 mL/min, Acknowledgements
tR of 1: between 1±200 mL 2: between 200±400 mL. Similarly
eluted were fractions 3±24 with an elution volume 200 mL S. W. A. B. thanks the Royal Society for an Industry Fellowship
each. Fractions 6±10 eluted with hexane/EtOAc '19:1) were and the Royal Society of Chemistry Journal Grant for visiting In-
combined '0.450 g) and recrystallised with hexane yielding com- dia.
pound 1 '0.125 g). TLC single spot, '10% EtOAc in hexane, R :
f
2
0
0
[
1
.45); m.p. 278 8C; [a] : + 0.28 'CHCl ) lit.[3], m.p. 278±2808C,
D 3
2
0
±1
a] : + 28; IR 'CCl ): n = 3600,1540,1460,1380,1030,1000 cm ; References
H-NMR '250.133 Hz, deuterated acetone): proton at C-7 four
peaks 6.5916, 6.5790, 6.5615, 6.5473 of equal intensities, methyl
protons 2.1297, 1.9809, 1.9632, 1.9459, 1.9333, 1.8556, 1.8017 '7
sets of methyl protons); elemental analysis found: C 84.35; H
D 4
1
2
Mujumdar AM, Naik DG, Waghole RJ, Kulkarni DK, Kumbhojkar MS.
Pharmacological studies on Sterculia foetida leaves. Pharm Biol 2000;
3
8: 13±7
Young JM, De Young LM. Pharmacological methods in the control of
inflammation. In: Spector J, Back N, editors. New York: Alan R. Liss,
Inc, 1989: pp 215±31
1
1.96; calculated for C H O: C 84.44; H 11.74%.
30 50
3
4
Brooks CJW. Observations on taraxerol 'skimmiol). J Chem Soc 1955:
Monoacetate 2, prepared by treating taraxer-14-en-3b-ol '1, 150
mg), with acetic anhydride was obtained as a colourless solid
125 mg); m.p. 297±299 8C; [a]2 : + 11.738 'CHCl ), 'lit. [4] m.p.
028C); IR 'CCl ): n = 1720, 1440, 1360, 1240, 1030, 1000 cm ;
elemental analysis found: C 76.47; H 11.64; calculated for
C H O '2H O): C 76.25; H 11.20%.
1674±7
Paul BD, Rao GS. Kapadia GJ. Isolation of myricadiol, myricitrin, tara-
xerol and taraxerone from Myrica cerifera L. root bark. J Pharmaceuti-
cal Sci 1974; 63: 958±9
Bates RB, Jacobsen NE, Setzer WN, Stessman CC. NMR assignments
and conformation of taraxerenes. Magnetic Resonance in Chemistry
1998; 36: 539±41
De Young L, Kheifts J, Young J. Edema and cell in filtration in the phor-
bol treated mouse ear are temporally separate and can be differential-
ly modulated by pharmacological agents. Agents and Actions 1989;
0
'
3
D
3
±
1
4
5
6
3
2
52
2
2
Taraxer-14-en-3-one '3, 71 mg) was obtained by Joneꢁs oxidation
of 1 '150 mg); m.p. 235±237 8C; [a] : + 14.478 'CHCl ), 'lit. [5]
m.p. 238±2398C); IR 'CCl ): n = 1720, 1460, 1380, 1000 cm ;
2
0
D
3
2
6: 335±41
±
1
4
elemental analysis found: C 85.14; H 11.31; calculated for
C H O: C 84.91; H 11.32%.
3
0
48
Animal experiments were conducted as per guidelines suggested
by the Committee for the Purpose of Control and Supervision of
Experiments on Animals 'CPCSEA) under Ministry of Statistics
and Programme Implementation, Government of India.
Male Swiss Albino mice were obtained from the National Insti-
tute of Virology, Pune. They were inbred in the animal house fa-
cilities at Agharkar Research Institute, for several generations for
the last 19 years. They were housed in polypropylene cages in an
air-conditioned area at 25 28C with 10 to 14 h light and dark cy-
cle and were given Amrut brand balanced animal feed and water
ad-libitum. A group of at least six animals was used for individual
treatments.
6
9
Ear oedema was induced [6] on the right ear by topical applica-
tion of TPA '2.5 mg in 20 mL of acetone). The left ear 'control) re-
ceived the vehicle 'acetone). The compound was applied at 0.25,
0
.5 and 1 mg/ear, respectively, immediately after application of
TPA. Indomethacin in a dose of 0.5 mg/ear was used as a positive
control. The thickness of ear was measured before and at 4 h
after application of TPA using a micrometer 'Digitrix mark II, Ja-
pan).
The oedema was expressed as mean SEM from these values and
these results were analysed by Studentꢁs t-test. Based on this the
percentage inhibition of inflammation and inhibition ratio at
0
.5 mg/ear were calculated to assess the anti-inflammatory ac-
tivity 'Table 1).
Letter¼ Planta Med 2004; 70: 68±69